RENOVIS
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and for the treatment of acute post-operative pain.
RENOVIS
Industry:
Innovation Management Medical Professional Services
Founded:
2000-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.renovis.com
Total Employee:
11+
Status:
Active
Contact:
(909)557-2360
Total Funding:
84.2 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail PHP Apache 2.4 Hetzner CentOS Salesforce SPF
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CDIB BioScience Ventures
CDIB BioScience Ventures investment in Series E - Renovis
HealthCap
HealthCap investment in Series E - Renovis
MDS Capital
MDS Capital investment in Series E - Renovis
Invus
Invus investment in Series E - Renovis
Easton Capital
Easton Capital investment in Series E - Renovis
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Renovis
International BM Biomedicine Holdings AG
International BM Biomedicine Holdings AG investment in Series B - Renovis
Flagship Pioneering
Flagship Pioneering investment in Series B - Renovis
Venrock
Venrock investment in Series B - Renovis
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series B - Renovis
Official Site Inspections
http://www.renovis.com
- Host name: 80-92-65-188.ip.dclux.com
- IP address: 80.92.65.188
- Location: Luxembourg
- Latitude: 49.4986
- Longitude: 5.9784
- Timezone: Europe/Luxembourg
